Bristol Myers Squibb to Report Results for First Quarter 2024 on April 25, 2024
11 Março 2024 - 5:16PM
Business Wire
Bristol Myers Squibb (NYSE: BMY) will announce results for the
first quarter of 2024 on Thursday, April 25, 2024. Company
executives will review financial results and address inquiries from
investors and analysts during a conference call beginning at 8:00
a.m. ET on the same date.
Investors and the general public are invited to listen to a live
webcast of the call at http://investor.bms.com. Investors and the
public can register for the live conference call here. Those unable
to register can access the live conference call by dialing in the
U.S. toll free 1-833-816-1116 or international +1 412-317-0705.
Materials related to the call will be available at
http://investor.bms.com prior to the start of the conference
call.
A replay of the webcast will be available at
http://investor.bms.com approximately three hours after the
conference call concludes. A replay of the conference call will be
available beginning at 11:30 a.m. ET on April 25, 2024, through
11:30 a.m. ET on May 9, 2024, by dialing in the U.S. toll free
1-877-344-7529 or international +1 412-317-0088, conference code:
5034750.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop and deliver innovative medicines
that help patients prevail over serious diseases. For more
information about Bristol Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter, YouTube, Facebook, and
Instagram.
corporatefinancial-news
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240311116567/en/
Media: media@bms.com Investors:
investor.relations@bms.com
Bristol Myers Squibb (NYSE:BMY)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Bristol Myers Squibb (NYSE:BMY)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024